FLUARIX TETRA av aig sép 2024/2025 0.5 ml
7680629610335
CH-62961
J07BB02
08.08.
Reimbursement limitations:
0808 NEU
La prise en charge des coûts des vaccins au titre de mesure préventive dans le …
1 / 3
google
Details
- Product number
- 6296111
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- haemagglutininum influenzae A (H1N1) (Virus Stamm A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Thailand/8/2022 (H3N2)-like: reassortant virus IVR-237 derived from A/Thailand/8/2022) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Austria/1359417/2021-like: reassortant virus BVR-26 derived from B/Austria/1359417/2021 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: B/Phuket/3073/2013 wild type (Yamagata lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum.
Articles (1)
Fluarix Tetra 15 µg / 0.5 ml, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
15.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
|
(N/A)
|
- | Substance | RESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 62961
- Drug name
- Fluarix Tetra, Injektionssuspension
- Galenic form
- SUPA
- ATC Code
- J07BB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 28/05/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUARIX TETRA av aig sép 2024/2025 0.5 ml
- Description (DE)
- FLUARIX TETRA m sep Nad 2024/2025 0.5 ml
- Market launch
- 10/07/2024
- Narcotic (BTM)
- No